| 000 | 01850 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250513231352.0 | ||
| 264 | 0 | _c20010308 | |
| 008 | 200103s 0 0 eng d | ||
| 022 | _a1355-8145 | ||
| 024 | 7 |
_a10.1379/1466-1268(2000)005<0401:ioahpt>2.0.co;2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChu, N R | |
| 245 | 0 | 0 |
_aImmunotherapy of a human papillomavirus type 16 E7-expressing tumor by administration of fusion protein comprised of Mycobacterium bovis BCG Hsp65 and HPV16 E7. _h[electronic resource] |
| 260 |
_bCell stress & chaperones _cNov 2000 |
||
| 300 |
_a401-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies _xpharmacology |
| 650 | 0 | 4 | _aBacterial Proteins |
| 650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _xcytology |
| 650 | 0 | 4 |
_aCD8 Antigens _xgenetics |
| 650 | 0 | 4 |
_aCD8-Positive T-Lymphocytes _xcytology |
| 650 | 0 | 4 | _aChaperonin 60 |
| 650 | 0 | 4 |
_aChaperonins _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGene Expression _ximmunology |
| 650 | 0 | 4 |
_aHistocompatibility Antigens Class II _xgenetics |
| 650 | 0 | 4 |
_aImmunotherapy _xmethods |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 |
_aMycobacterium bovis _xgenetics |
| 650 | 0 | 4 |
_aOncogene Proteins, Viral _xgenetics |
| 650 | 0 | 4 | _aPapillomavirus E7 Proteins |
| 650 | 0 | 4 |
_aRecombinant Fusion Proteins _xgenetics |
| 650 | 0 | 4 |
_aSpleen _xcytology |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 |
_aUterine Cervical Neoplasms _ximmunology |
| 700 | 1 | _aWu, H B | |
| 700 | 1 | _aWu, T C | |
| 700 | 1 | _aBoux, L J | |
| 700 | 1 | _aMizzen, L A | |
| 700 | 1 | _aSiegel, M I | |
| 773 | 0 |
_tCell stress & chaperones _gvol. 5 _gno. 5 _gp. 401-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1379/1466-1268(2000)005<0401:ioahpt>2.0.co;2 _zAvailable from publisher's website |
| 999 |
_c11127643 _d11127643 |
||